Paclitaxel-Eluting Stent Long-Term Outcomes in Percutaneous Saphenous Vein Graft Interventions (PELOPS) Study

American Journal of Cardiology

Volumn 103, Issue 2, 2009, Pages 199-202

  Jim, Man Hong ^a   Ho, Hee Hwa ^a   Ko, Ryan Lap yan ^b   Yiu, Kai Hang ^b   Siu, Chung Wah ^b   Lau, Chu Pak ^b   Chow, Wing Hing ^a  

^a GRANTHAM HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR; GLYCERYL TRINITRATE; GLYCOPROTEIN IIB IIIA INHIBITOR; HEPARIN; PACLITAXEL; UNCLASSIFIED DRUG;

AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL CARE; HUMAN; IMPLANTATION; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; TREATMENT DURATION; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SAPHENOUS VEIN; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 58149464826     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.057     Document Type: Article

References (30)

1. Alexander J.H., Hafley G., Harrington R.A., Peterson E.D., Ferguson T.B., Lorenz T.J., Goyal A., Gibson M., Mack M.J., Gennevois D., Califf R.M., Kouchoukos N.T., and PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294 (2005) 2446-2454
2. Fitzgibbon G.M., Leach A.J., Kafka H.P., and Keon W.J. Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol 17 (1991) 1075-1080
3. Weintraub W.S., Jones E.L., Morris D.C., King III S.B., Guyton R.A., and Craver J.M. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 95 (1997) 868-877
4. Salomon N., Page U., Bigelow J., Krause A.H., Okies J.E., and Metzdorff M.T. Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass. J Thorac Cardiovasc Surg 100 (1990) 250-259
5. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnàr F., Falotico R., and RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
6. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
7. Vermeersch P., Agostoni P., Verheye S., Van den Heuvel P., Converns C., Bruining N., Van den Branden F., and Van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48 (2006) 2423-2431
8. Chu W.W., Rha S.W., Kuchulakanti P.K., Cheneau E., Torguson R., Pinnow E., Alexieva-Fournadjiev J., Pichard A.D., Satler L.F., Kent K.M., Lindsay J., and Waksman R. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 97 (2006) 34-37
9. Vermeersch P., Agostoni P., Verheye S., Van den Heuvel P., Converns C., Van den Branden F., and Van Langenhove G. DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol 50 (2007) 261-267
10. Hoffmann R., Pohl T., Köster R., Blindt R., Boeckstegers P., and Heitzer T. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. Heart 93 (2007) 331-334
11. Saucedo J.F., Mehran R., Dangas G., Hong M.K., Lansky A., Kent K.M., Satler L.F., Pichard A.D., Stone G.W., and Leon M.B. Long-term clinical events following creatinine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 35 (2000) 1134-1141
12. Smith S.C., Feldman T.E., Hirshfeld J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neil W.W., Schaff H.V., Whitlow P.L., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation (2006) 113:e166-286
13. Savage M.P., Douglas J.S., Fischman D.L., Pepine C.J., King III S.B., Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., Leon M.B., Goldberg S., and Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 337 (1997) 740-747
14. Wong S.C., Baim D.S., Schatz R.A., Teirstein P.S., King III S.B., Curry R.C., Heuser R.R., Ellis S.G., Cleman M.W., Overlie P., et al., Palmaz-Schatz Stent Study Group. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the Multicenter US Palmaz-Schatz Stent Experience. J Am Coll Cardiol 26 (1995) 704-712
15. Hanekamp C.E., Koolen J.J., den Heijer P., Schalij M.J., Piek J.J., Bär F.W., De Scheerder I., Bonnier H.J., Pijls N.H., and Venestent Study Group. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass graft: the Venestent Study. Catheter Cardiovasc Interv 60 (2003) 452-457
16. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., Corvaja N., and Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents. J Am Coll Cardiol 45 (2005) 989-994
17. Elezi S., Kastrati A., Pache J., Wehinger A., Hadamitzky M., Dirschinger J., and Neumann F.J. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32 (1998) 1866-1873
18. Ahmed J.M., Hong M.K., Mehran R., Dangas G., Mintz G.S., Pichard A.D., Satler L.F., Kent K.M., Wu H., Stone G.W., and Leon M.B. Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting. J Am Coll Cardiol 36 (2000) 1186-1193
19. Lorusso R., Pentiricci S., Raddino R., Scarabelli T.M., Zambelli C., Villanacci V., Burattin A., Romanelli G., Casari S., Scelsi R., and Giustina A. Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. Diabetes 52 (2003) 2814-2820
20. Aaltomaa S., Hippelainen M., and Lipponen P. Cell proliferation in aortic, mammary artery and saphenous vein biopsies in patients subjected to open heart surgery. In Vivo 11 (1997) 243-247
21. Carrozza J.P., Kuntz R.E., Fishman R.F., and Baim D.S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 118 (1993) 344-349
22. Kirtane A.J., Ellis S.G., Dawkins K.D., Colombo A., Grube E., Popma J.J., Fahy M., and Leon M.B. Paclitaxel-eluting coronary stents in patients with diabetes mellitus. J Am Coll Cardiol 51 (2008) 708-715
23. Togni M., Eber S., Widmer J., Billinger M., Wenaweser P., Cook S., Vogel R., Seiler C., Eberli F.R., Maier W., et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol 50 (2007) 1123-1131
24. Elezi S., Dibra A., Mehilli J., Pache J., Wessely R., Schömig A., and Kastrati A. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. J Am Coll Cardiol 48 (2006) 1304-1309
25. Keeley E.C., Velez C.A., O'Neill W.W., and Safian R.D. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 38 (2000) 659-665
26. Roffi M., Mukherjee D., Chew D.P., Bhatt D.L., Cho L., Robbins M.A., Ziada K.M., Brennan D.M., Ellis S.G., and Topol E.J. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts. A pooled analysis of five randomized clinical trials. Circulation 106 (2003) 3063-3067
27. Coolong A., Baim D.S., Kuntz R.E., O'Malley A.J., Marulkar S., Cutlip D.E., Popma J.J., and Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation 117 (2008) 790-797
28. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., Peterson E.D., Schulman K.A., and Califf R.M. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
29. Matsumoto D., Shite J., Shinke T., Otake H., Tanino Y., Ogasawara D., Sawada T., Paredes O.L., Hirata K., and Yokoyama M. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
30. Kotani J., Awata M., Nanto S., Uematsu M., Oshima F., Minamiguchi H., Mintz G.S., and Nagata S. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111